The advent of GLP-1 therapies has been a game changer in the medical sector in the field of weight loss and chronic obesity. The GLP-1 market is currently dominated by semaglutide (Ozempic and Wegovy), manufactured by Novo Nordisk A/S New York Stock Exchange: HBO and tirzepatide (Mounjaro and Zepbound), produced Eli Lilly and Co. New … Read more
2025 looks set to be a banner year for nuclear energy companies. Energy demand has never been higher: The US Energy Information Administration estimates that total electricity demand in the United States will be 4.1 trillion kilowatt-hours (kWh) in 2024, a record, and estimates for 2025 are even higher. In addition, demand is particularly high … Read more
The oil price outlook is good for energy companies as they are depressed and at an average long-term low for the fourth quarter and at an extreme that is likely to rise as the year progresses. This means that energy company earnings forecasts are likely too low and that a productivity/upgrade cycle is about to … Read more